Patents by Inventor Alfonso BLAZQUEZ-CASTRO

Alfonso BLAZQUEZ-CASTRO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

Use of a photosensitive agent capable of producing reactive oxygen species in the production of a drug for the photodynamic therapy of a disease related to stem cells, in vitro use, and pharmaceutical composition

Patent number: 10695428

Abstract: The invention relates to the use of a photosensitive agent, or the precursor thereof, capable of producing reactive oxygen species (ROS) in the production of a drug that can be used for the photodynamic therapy (PDT)-based treatment of a disease related to a patient's stem cells, preferably epidermal stem cells.

Type: Grant

Filed: November 11, 2013

Date of Patent: June 30, 2020

Assignees: UNIVERSIDAD AUTONOMA DE MADRID, CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS

Inventors: Jesus Espada Regalado, Elisa Carrasco Cerro, María Inmaculada Calvo Sanchez, Alfonso Blazquez-Castro, Angeles Juarranz De La Fuente
USE OF A PHOTOSENSITIVE AGENT CAPABLE OF PRODUCING REACTIVE OXYGEN SPECIES IN THE PRODUCTION OF A DRUG FOR THE PHOTODYNAMIC THERAPY OF A DISEASE RELATED TO STEM CELLS, IN VITRO USE, AND PHARMACEUTICAL COMPOSITION

Publication number: 20150335746

Abstract: The invention relates to the use of a photosensitive agent, or the precursor thereof, capable of producing reactive oxygen species (ROS) in the production of a drug that can be used for the photodynamic therapy (PDT)-based treatment of a disease related to a patient's stem cells, preferably epidermal stem cells.

Type: Application

Filed: November 11, 2013

Publication date: November 26, 2015

Inventors: Jesus ESPADA REGALADO, Elisa CARRASCO CERRO, María Inmaculada CALVO SANCHEZ, Alfonso BLAZQUEZ-CASTRO, Angeles JUARRANZ DE LA FUENTE

Use of a photosensitive agent capable of producing reactive oxygen species in the production of a drug for the photodynamic therapy of a disease related to stem cells, in vitro use, and pharmaceutical composition

USE OF A PHOTOSENSITIVE AGENT CAPABLE OF PRODUCING REACTIVE OXYGEN SPECIES IN THE PRODUCTION OF A DRUG FOR THE PHOTODYNAMIC THERAPY OF A DISEASE RELATED TO STEM CELLS, IN VITRO USE, AND PHARMACEUTICAL COMPOSITION